TAF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.908800E-01
Normal-vs-Stage2
7.231200E-01
Normal-vs-Stage3
1.242420E-01
Normal-vs-Stage4
8.005000E-01
Stage1-vs-Stage2
9.581600E-01
Stage1-vs-Stage3
7.572100E-02
Stage1-vs-Stage4
9.179400E-01
Stage2-vs-Stage3
3.812400E-02
Stage2-vs-Stage4
9.517200E-01
Stage3-vs-Stage4
1.857410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.631200E-01
Normal-vs-AfricanAmerican
9.206600E-01
Normal-vs-Asian
4.593000E-01
Caucasian-vs-AfricanAmerican
6.416800E-01
Caucasian-vs-Asian
3.637000E-01
AfricanAmerican-vs-Asian
3.947600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.146600E-01
Normal-vs-Female
4.118400E-01
Male-vs-Female
8.108200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.999000E-01
Normal-vs-Age(41-60Yrs)
8.471400E-01
Normal-vs-Age(61-80Yrs)
5.790200E-01
Normal-vs-Age(81-100Yrs)
5.837400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.151200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.220800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.840000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.343380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.102600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.843800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.622400E-01
Normal-vs-Daily Drinker
7.533800E-01
Normal-vs-Weekly Drinker
6.744000E-01
Normal-vs-Occasional Drinker
9.441600E-01
Normal-vs-Social Drinker
5.730800E-01
Non Drinker-vs-Daily Drinker
8.389400E-01
Non Drinker-vs-Weekly Drinker
8.994000E-01
Non Drinker-vs-Occasional Drinker
3.032400E-01
Non Drinker-vs-Social Drinker
9.288800E-01
Daily Drinker-vs-Weekly Drinker
9.543600E-01
Daily Drinker-vs-Occasional Drinker
5.602600E-01
Daily Drinker-vs-Social Drinker
9.205000E-01
Weekly Drinker-vs-Occasional Drinker
4.890200E-01
Weekly Drinker-vs-Social Drinker
9.673200E-01
Occasional Drinker-vs-Social Drinker
3.992400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.799850E-01
Normal-vs-Grade 2
3.940500E-02
Normal-vs-Grade 3
2.223800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.149800E-01
Grade 1-vs-Grade 3
3.104300E-03
Grade 1-vs-Grade 4
1.799850E-01
Grade 2-vs-Grade 3
1.512100E-02
Grade 2-vs-Grade 4
3.940500E-02
Grade 3-vs-Grade 4
2.223800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.200600E-01
Normal-vs-NonDiabetic
7.513200E-01
Diabetic-vs-NonDiabetic
5.169800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.647000E-01
Normal-vs-NoPancreatitis
6.099200E-01
Pancreatitis-vs-NoPancreatitis
6.302400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.300800E-01
Normal-vs-N1
6.959800E-01
N0-vs-N1
5.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.998200E-01
Normal-vs-TP53-NonMutant
7.376200E-01
TP53-Mutant-vs-TP53-NonMutant
1.807790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
